20041 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Pulmonary tract; Aromatherapy
Sub-classes:POLY(AMINE-CO-ESTER) POLYMERIC PARTICLES FOR SELECTIVE PULMONARY DELIVERY
#2COMPOSITION FOR NON-PYROTECHNIC GENERATION OF SMOKE
#3Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient
#4AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE
#5HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS
#6VIRUS-LIKE PARTICLES FOR PREVENTING THE SPREADING AND LOWERING THE INFECTION RATE OF VIRUSES
#7HYDROGEN-GAS-CONTAINING DRUG FOR CAUSAL TREATMENT OF ALZHEIMER'S DISEASE (DISEASE-MODIFYING DRUG)
#8ALPHA-V BETA-6 (avb6) INTEGRIN LIGANDS FOR EXTRAHEPATIC DELIVERY
#9CANNABIS COMPOSITIONS AND METHODS
#10INHALATION DEVICE FOR 7-OH-MITRAGYNINE
#11USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#12METHODS OF INDUCING ANESTHESIA
#13CONSUMER PRODUCT TABLET USING DIRECT COMPRESSION
#14COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF PREPARATION AND USE THEREOF
#15COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
#16METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM
#17INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#18BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS
#19SCENT DISPENSERS/ABSORBERS AND SCENT CARTRIDGES THEREFOR
#20Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders
#21DRY EYE TREATMENTS
#22Vaporized Medicants and Methods of Use
#23METHODS OF TREATING OCULAR CONDITIONS
#24Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient
#25TOXIN-DERIVED DELIVERY CONSTRUCTS
#26CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#27METHODS OF TREATING OCULAR CONDITIONS
#28METHODS OF TARGETED DELIVERY TO A HOST USING A CARRIER
#29TREATMENT OR PREVENTION OF RESPIRATORY DISEASES CHARACTERISED BY, OR INVOLVING, LUNG FIBROSIS
#30VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A TLR3 AGONIST
#31COMPOSITIONS COMPRISING AT LEAST ONE OF A TERPENE AND A CANNABINOID AND USES THEREOF
#32METHOD AND DEVICE FOR VAPORIZATION AND INHALATION OF ISOLATED SUBSTANCES
#33DRUG DOSE CARTRIDGE FOR AN INHALER DEVICE
#34NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF
#35NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF
#36METHODS, DEVICES AND SYSTEMS FOR PULMONARY DELIVERY OF ACTIVE AGENTS
#37NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF
#38ALCOHOL CLEANSING METHODS
#39CARRIER FOR LOWERING THE INFECTION RATE OF BACTERIA
#40METHOD FOR PULMONARY FOAM DELIVERY
#41ACYL NORNICOTINES REDUCE SENSORY IRRITATION IN TOBACCO AND NICOTINE PRODUCTS
#42METHODS FOR TREATING NONTUBERCULOUS MYCOBACTERIA DISEASES
#43AUTOMATED PRODUCTION OF VIRAL VECTORS
#44USE OF ALVEOLAR OR AIRWAY ORGANOIDS FOR THE TREATMENT OF LUNG DISEASES AND DISORDERS
#45Methods of fabricating carriers for targeted delivery to a host
#46COMPOSITIONS, METHODS AND USES OF MESSENGER RNA
#47Articles Formed of Pulp Base Materials With Modulated Scent Release
#48Surfactant Lipids, Compositions Thereof, and Uses Thereof
#49STEM CELL FACTOR INHIBITOR
#50INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT
#51METHODS OF SUPPRESSING MICROGLIAL ACTIVATION
#52VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF
#53METHODS FOR TREATMENT OF PULMONARY HYPERTENSION
#54LIQUID VAPE BASE AND EXTRACTION PROCESS
#55RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of Use
#56NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMER'S DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING
#57DENDRITIC CONJUGATES FOR THE LUNG DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES
#58GENE THERAPY FOR TUBEROUS SCLEROSIS
#59WEARABLE PET DEVICES WITH PASSIVE DIFFUSION OF SEMIOCHEMICAL COMPOSITIONS
#60FLOW REGULATING INHALER DEVICE
#61ALGAE-BASED MICROROBOT FOR DRUG DELIVERY
#62MICROWAVE HEATING UNIT AND METHOD
#63TOXIN-DERIVED DELIVERY CONSTRUCTS
#64COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS
#65IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY TO THE LUNG
#66VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF
#67NICOTINE GEL
#68TREATMENT OF ACUTE HEART FAILURE USING NITROUS OXIDE AND CHRONIC HEART FAILURE USING BOTULINUM TOXIN
#69INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#70USE OF CELLULAR MICROPARTICLES IN TREATMENT OF RESPIRATORY VIRAL PNEUMONIA
#71INHALABLE COMPOSITIONS COMPRISING CAFFEINE, METHODS OF USE AND AN APPARATUS FOR USING THE SAME
#72KETAMINE AND CANNABIS FOR THE TREATMENT OF EMOTIONAL DISORDERS
#73SUBSTRATE FOR DELIVERING A BIOLOGICALLY ACTIVE SUBSTANCE
#74USE OF ULTRARAPID ACTING INSULIN
#75NANOTHERAPEUTICS FOR TREATMENT OF SARS-COV-2
#76DRY EYE TREATMENTS
#77EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR PREPARATION, AND USES
#78PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR
#79Carrier for targeted delivery to a host
#80ASSOCIATIONS OF FOSFOMYCIN AND COLISTIN FOR USE AGAINST BIOFILM-ASSOCIATED BACTERIAL INFECTIONS
#81PHEROMONE DIFFUSING GEL
#82METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM
#83LOCALIZED THERAPY OF LOWER AIRWAYS INFLAMMATORY DISORDERS WITH PROINFLAMMATORY CYTOKINE INHIBITORS
#84BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS
#85Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#86METHODS FOR REMOVING PESTICDES FROM CANNABIS PRODUCTS
#87VAPORIZING DEVICES AND METHODS FOR DELIVERING A COMPOUND USING THE SAME
#88Automated production of viral vectors
#89INHALABLE FORMULATIONS
#90Method for Pleurodesis and Delivery of Drugs to the Lung and Pleural Space
#91PREPARATIONS CONTAINING MITRAGYNE EXTRACT OR ITS ISOLATED ALKALOIDS AND CANNABIS EXTRACT OR ITS ISOLATED CANNABINOIDS, AND COSMETIC AND/OR PHARMACEUTICAL USE THEREOF
#92INHALED FORMULATIONS OF PGDH INHIBITORS AND METHODS OF USE THEREOF
#93METHOD AND SYSTEM FOR DRUG DELIVERY
#94Mutant Bordetella Strains and Methods of Use
#95Terpene Inhalant
#96TES-BASED CATIONIC LIPIDS
#97NEIL2 PROTEIN THERAPY FOR TREATMENT OF VIRAL INFECTION
#98METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES
#99Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
#100VAPORIZER FOR VAPORIZING A CONSTITUENT OF A PLANT MATERIAL
#101TREATMENT OF A VIRAL PANDEMIC USING CIGARETTES WITH ADDED NITRATES
#102METHOD FOR OPERATING DEVICE USING MULTI-STAGE HEATING
#103COMPOSITIONS AND METHODS FOR PREVENTING AND/OR AMELIORATING ORGAN-SPECIFIC AUTOIMMUNE DISEASES
#104USE OF LEOLIGIN IN THE PREVENTION OF TISSUE DAMAGE
#105USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#106Heating unit for use in a drug delivery device
#107METHODS, ANHYDROUS COMPOSITIONS AND APPLICATORS FOR DELIVERY OF NUTRITIONAL SUPPLEMENTS WHILE CONCURRENTLY/SIMULTANEOUSLY PROVIDING AROMATHERAPY
#108TREATMENT OF PRIMARY AND/OR SECONDARY LUNG TUMORS USING GASEOUS NITRIC OXIDE INHALATION
#109CANNABIDIOL INFUSED CANDLE
#110ANTI-VIRAL COMPOUNDS AND METHODS FOR ADMINISTRATION THEREOF
#111USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#112Vaporized medicants and methods of use
#113CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#114TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#115COMPOSITION FOR TREATING AND/OR PREVENTING COGNITIVE IMPAIRMENT OR DEMENTIA
#116Compositions and use of varenicline for treating dry eye
#117Compositions and use of varenicline for treating dry eye
#118Compositions and use of varenicline for treating dry eye
#119LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION
#120Anti-viral agents and methods for administration thereof
#121Influenza virus replication for vaccine development
#122ISTHMIN 1 FOR TREATMENT OF LUNG INFLAMMATION
#123PLANT EXTRACTS AND THERAPEUTIC COMPOUNDS IN SMOKING UTENSILS AND IN HONEY COMPLEXES
#124Virus-like particles for preventing the spreading and lowering the infection rate of viruses
#125PHYTO MATERIAL TABLET, METHOD AND APPARATUS
#126Articles formed of pulp base materials with modulated scent release
#127TOXIN-DERIVED DELIVERY CONSTRUCTS
#128USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
#129HMGB1 antagonist treatment of severe sepsis
#130COMPOSITIONS AND USES OF LOCALLY APPLIED SYNTHETIC AMINO ACID POLYMERS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
#131COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION
#132CAR Peptide for Improved Coronavirus Survival
#133CANNABINOID COMPOSITIONS AND AEROSOLS
#134MEANS AND METHODS FOR ENHANCING CANNABINOIDS EFFICACY
#135Processes for Breaching Blood-Brain Barrier
#136IL-1 Binding Proteins
#137HYDROGEN CONTAINING COMPOSITION AND METHODS OF USING THE SAME
#138INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#139ELECTRONIC VAPOR LIQUID COMPOSITION AND METHOD OF USE
#140TISSUE DOSING FOR INTRALUMINAL LOCAL DRUG DELIVERY
#141METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS
#142STRESS MANAGEMENT IN HUMAN SUBJECTS IN NEED THEREOF
#143METHODS OF USING INHALED NITRIC OXIDE GAS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME IN CHILDREN
#144Inhalers and related methods
#145AMINO-PYRIMIDINE SKELETAL MUSCLE MODULATORS
#146Inhalers and related methods
#147IMPROVEMENTS IN WEIGHT CONTROL
#148Method of identifying and treating premature infants at risk for BPD
#149COMBINATION CANNABINOID-NAD+ PRECURSOR FORMULATION FOR TREATMENT OF INFLAMMATION AND METHODS RELATED THERETO
#150NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREIN
#151System and Method of Using Hypochlorous Acid Made from Saltwater with Sodium Bicarbonate
#152THERAPY GARMENT FOR DELIVERING AROMATHERAPY AND MEDICINAL BENEFITS AND METHODS OF MAKING AND USING THE SAME
#153Process for the preparation of a PDE4 inhibitor
#154Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
#155MICROWAVE HEATING UNIT AND METHOD
#156INHALABLE GASEOUS MIXTURE FOR TREATING CHRONIC PAIN IN PATENTS RECEIVING DRUGS FROM MULTIPLE THERAPEUTIC CLASSES
#157FLOWABLE CANNABINOID COMPOSITIONS HAVING HIGH EFFECTIVE CONCENTRATIONS
#158SYNTHETIC ANTIMICROBIAL PEPTIDES
#159METHODS OF INDUCING ANESTHESIA
#160MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTING OR IMPROVING OSTEOPOROSIS
#161COMPOSITIONS AND METHODS FOR IN UTERO GENE EDITING FOR MONOGENIC LUNG DISEASE
#162Virus-like particles for preventing the spreading and lowering the infection rate of viruses
#163A METHOD OF ADMINISTERING NITRIC OXIDE GAS
#164USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#165Flow regulating inhaler device
#166WOUND-TREATING GAS COMPOSITION, AND WOUND-TREATING APPARATUS
#167Surfactant Lipids, Compositions Thereof, and Uses Thereof
#168INHALABLE IMATINIB FORMULATION
#169TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS
#170Combination therapy effective against microorganisms, including drug resistant microorganisms
#171Compositions and use of varenicline for treating dry eye
#172JAK1 SELECTIVE KINASE INHIBITOR
#173Methods, devices and systems for pulmonary delivery of active agents
#174DOSAGE FORMS FOR PREVENTING DRUG-FACILITATED ASSAULT
#175Nasal Inhaler Band
#176LIPOCALIN MUTEIN FOR TREATMENT OF ASTHMA
#177METHOD AND DEVICE FOR VAPORIZATION AND INHALATION OF ISOLATED SUBSTANCES
#178Method and system for protecting monarch butterflies from pesticides
#179USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#180Parenteral Formulation
#181COMPOSITIONS FOR DELIVERY OF CODON-OPTIMIZED MRNA
#182Immolative cell-penetrating complexes for nucleic acid delivery to the lung
#183IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS
#184ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS
#185HEMOSTATIC COMPOSITIONS AND METHODS OF MAKING THEREOF
#186Method of identifying a biologically-active composition from a biofilm
#187Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#188COMPOSITION FOR INHIBITING RESPIRATORY VIRUSES AND RESPIRATORY VIRUS PREVENTION AND TREATMENT METHOD
#189Inorganic nitrite to improve cardiopulmonary hemodynamics
#190CRYSTALLINE SPIROCYCLIC COMPOUND, A DOSAGE FORM CONTAINING, A METHOD FOR USING IN TREATMENT OF DISEASE, AND A METHOD FOR RECRYSTALLIZING
#191CANNABIS COMPOSITIONS AND METHODS
#192Liquid nicotine formulation comprising low molar mass metal salt
#193INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#194THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE TREATMENT OF EVOLVING BPD
#195DRUG DOSE CARTRIDGE FOR AN INHALER DEVICE
#196POLY(AMINE-CO-ESTER) POLYMERIC PARTICLES FOR SELECTIVE PULMONARY DELIVERY
#197PURIFIED MESENCHYMAL STEM CELL EXOSOMES AND USES THEREOF
#198STEM CELL FACTOR INHIBITOR
#199METHODS OF TREATING DISEASES RELATED TO NET FORMATION WITH PARENTERAL ADMINISTRATION OF POLYSIALYLATED DNASE I
#200Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#201Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia
#202Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition
#203GAS MIXTURES CONTAINING LOW CONCENTRATIONS OF XENON AND ARGON PROVIDE NEUROPROTECTION WITHOUT INHIBITING THE CATALYTIC ACTIVITY OF THROMBOLYTIC AGENTS
#204CANNABIS PLANT FORMULATIONS AND METHODS OF DELIVERY
#205Dosage form for vaporization and smoking
#206Methods of treating SARS-CoV-2 infections
#207COMPOSITION AND METHOD FOR TREATMENT OF RESPIRATORY DISORDERS
#208METHODS FOR IMPROVING DRUG EFFICACY
#209Halogenated ether compounds and methods of inducing anesthesia
#210CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#211METHOD FOR ACCELERATED TISSUE PENETRATION OF COMPOUNDS INTO BRAIN
#212METHODS OF INDUCING ANESTHESIA
#213COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND TREATING VIRAL INFECTIONS
#214COMPLETE UPPER RESPIRATORY TRACT CLEANSING SYSTEM AND ITS USE
#215MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF ENCEPHALITIS AND/OR MENINGITIS AND SYMPTOM ASSOCIATED WITH THE ENCEPHALITIS AND/OR MENINGITIS
#216Methods for removing pesticides from products
#217DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES
#218Mutant Bordetella Strains and Methods of Use
#219MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR REGULATING INTRACELLULAR SIGNAL TRANSDUCTION
#220MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF GENETIC DISORDER
#221COMPOSITION FOR IMPROVING RENAL FUNCTION IN RENAL DISEASES CONTAINING MOLECULAR HYDROGEN
#222MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF PNEUMONIA
#223Cannabis product
#224Aerosolizable gel
#225Whitened turmeric product for the prevention of viral infections
#226Use of ultrarapid acting insulin
#227NUCLEIC ACID MOLECULES AND DUAL-FUNCTIONAL PEPTIDES HAVING ANTIVIRAL ACTIVITY AND DELIVERY ACTIVITY, COMPOSITIONS AND METHODS THEREOF
#228Treatment of infections and associated pathophysiological conditions
#229Method and system for drug delivery
#230TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#231NEURONAL AGONISTS AND ISOTONIC OR HYPERTONIC SALINE FOR TREATING RESPIRATORY DISEASES
#232Pharmaceutical composition for treating fibrosis
#233Combination treatment for cystic fibrosis
#234Nicotine salt formulations for aerosol devices and methods thereof
#235LIGHT INHIBITORS FOR ASTHMA, LUNG AND AIRWAY INFLAMMATION, RESPIRATORY, INTERSTITIAL, PULMONARY AND FIBROTIC DISEASE TREATMENT
#236Articles formed of pulp base materials with modulated scent release
#237Method and system for protecting honey bees from pesticides
#238GASEOUS PHARMACEUTICAL COMPOSITION FOR HYPERTENSION THERAPY
#239Aerosolizable gel
#240Use of inhibitors of Brutons tyrosine kinase (Btk)
#241Vaporized medicants and methods of use
#242CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
#243METHODS FOR INTEGRATIVE DIAGNOSIS AND TREATMENT AND A KIT FOR THEIR IMPLEMENTATION
#244Substituted benzodiazoliums as ENaC inhibitors
#245Capsaicinoid smoke
#246CANNABINOID COMPOSITIONS IN CARBOXYLATED INACTIVE FORM
#247Plant extracts and therapeutic compounds in smoking utensils and in honey complexes
#248PURIFIED MESENCHYMAL STEM CELL EXOSOMES AND USES THEREOF
#249TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATMENT OF MALE SUBJECTS
#250Lidocaine n-oxide for use in the prophylaxis of sudden cardiac death
#251Toxin-derived delivery constructs for pulmonary delivery
#252Compositions, methods and uses of messenger RNA
#253USE OF PLATELETS IN TREATING INFECTIONS
#254FLAVORED BIOACTIVE EXTRACTS AND METHODS OF FLAVOR INTRODUCTION
#255COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
#256Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders
#257VESICLE-ENCAPSULATED SOCS
#258ELECTRONIC CIGARETTE
#259Nicotine gel
#260NON-BURNING TYPE FLAVOR INHALER AND CONTROL METHOD
#261Influenza virus replication for vaccine development
#262COMPOSITIONS AND METHODS FOR THE TREATMENT OF LUNG EMPHYSEMA AND OTHER FORMS OF COPD
#263USE OF ANTISTATIC MATERIALS IN THE AIRWAY FOR THERMAL AEROSOL CONDENSATION PROCESS
#264Tuberculosis vaccine, preparation method therefor, and use thereof
#265Temperature-controlled semiochemical composition diffusers
#266Amino-pyrimidine skeletal muscle modulators
#267Process for the preparation of a PDE4 inhibitor
#268S1PR2 ANTAGONISTS FOR TREATING DISEASES INVOLVING ABNORMAL IMMUNE RESPONSES
#269Use of alveolar or airway organoids for the treatment of lung diseases and disorders
#270Nucleic acid aptamers to treat histone-induced disease states
#271Vaporizing devices and methods for delivering a compound using the same
#272Nicotine gel
#273PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY
#274COMPOSITION FOR GENE THERAPY OF THE CENTRAL NERVOUS SYSTEM, PROCESS OF PRODUCTION AND USE THEREOF
#275Prodrug derivatives of protein kinase C modulators
#276HMGB1 antagonist treatment of severe sepsis
#277Treatment of Middle East respiratory syndrome coronavirus
#278Pulsed Administration Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension
#279OIL-INFUSED ELASTOMERIC THERAPEUTIC DEVICE
#280LIPID NANO PARTICLE COMPLEX COMPRISING APTIDE FUSED WITH CELL PENETRATING MATERIALS AND USE SAME
#281Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#282ANTI-FLT-1 ANTIBODIES IN TREATING BRONCHOPULMONARY DYSPLASIA
#283Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary Hypertension
#284Unit aerosol doses for anticoagulation
#285HMGB1 antagonist treatment of acute lung injury
#286HMGB1 antagonist treatment of diabetic peripheral neuropathy
#287HMGB1 antagonist
#288COMPOSITION FOR IMPROVING THE WELL-BEING OF ANIMALS
#289PREVENTIVE AND/OR THERAPEUTIC AGENT FOR DEMENTIA
#290INHALABLE COMPOSITIONS COMPRISING CAFFEINE, METHODS OF USE AND AN APPARATUS FOR USING THE SAME
#291Oxadiazole derivatives as Rho-Kinase Inhibitors
#292METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 AND FATTY ACID METABOLISM INHIBITORS
#293Mutant strains and methods of use
#294Pharmaceutical composition for suppressing spinal cord ischemic disorder
#295Surfactant Lipids, Compositions Thereof, and Uses Thereof
#296pH-Modulated Formulations for Pulmonary Delivery
#297Method and system for protecting honey bees from pesticides
#298Cannabinoid compositions and methods of use thereof
#299METHODS AND COMPOSITIONS FOR REDUCING LUNG INJURY ASSOCIATED WITH LUNG TRANSPLANTATION
#300INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES